SEC Form 4 · accession 0001144204-18-013436

Chiron Real Estate Inc. · XRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Investment Officer

Period of report

Mar 5, 2018

Accepted (ET)

Mar 7, 2018 · 8:11 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001533615

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
LTIP Unit (Right to Buy)^F1,F3,F2	—	Mar 5, 2018	A	8,182	A	—	—	Common Stock	8,182	37,956	D
LTIP Unit (Right to Buy)^F4,F2	—	Mar 5, 2018	A	12,140	A	—	—	Common Stock	12,140	50,096	D

F1Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2018 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2017 and 50% of the LTIP Units will vest on December 31, 2018, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.
F2As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.
F3Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.1 to the Issuer's Current Report on Form 8-K filed on March 6, 2017.
F4LTIP Units vest in equal one-third installments on March 5 of 2019, 2020 and 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

Exhibit List: Exhibit 24: Power of Attorney